Abiopharma

🔍 PLATT PHILLIP JOHN (Executive)

Company: Ingevity Corp (NGVT)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 1,262 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 31,633.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Grant of restricted stock units ("RSUs") pursuant to the Ingevity Corporation 2025 Omnibus Incentive Plan, which will vest in three equal installments on May 1, 2027, 2028, and 2029.
• F2: Includes 422 shares of Common Stock purchased pursuant to the Amended and Restated 2017 Ingevity Corporation Employee Stock Purchase Plan, as amended ("ESPP"), for the purchase period of January 1, 2026 to March 31, 2026. In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on December 31, 2025.